{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:06:38Z","timestamp":1790071598482,"version":"4.0.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"DOI":"10.1007\/s00417-026-07476-x","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:36:27Z","timestamp":1790069787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics, outcomes, and immunosuppressive strategies in sympathetic ophthalmia: real-world experience from a french tertiary center"],"prefix":"10.1007","author":[{"given":"Nicolas","family":"Kitic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e9la\u00efde","family":"Tout\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Touitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apolline","family":"Auger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Massamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafik","family":"Belazzougui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Fardeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Kitic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine","family":"Ghembaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Claire","family":"Desbois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thouraya Ben","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Hie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Domont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Bodaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"issue":"3","key":"7476_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/bjo.84.3.259","volume":"84","author":"DJ Kilmartin","year":"2000","unstructured":"Kilmartin DJ, Dick AD, Forrester JV (2000) Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol 84(3):259\u2013263. https:\/\/doi.org\/10.1136\/bjo.84.3.259 PMID: 10684834; PMCID: PMC1723405","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"7476_CR2","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1080\/09273948.2022.2058554","volume":"31","author":"M Agarwal","year":"2023","unstructured":"Agarwal M, Radosavljevic A, Tyagi M et al (2023) Sympathetic Ophthalmia - An Overview. Ocul Immunol Inflamm 31(4):793\u2013809. https:\/\/doi.org\/10.1080\/09273948.2022.2058554 Epub 2022 May 17. PMID: 35579612","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"7476_CR3","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.ajo.2009.05.033","volume":"148","author":"A Galor","year":"2009","unstructured":"Galor A, Davis JL, Flynn HW Jr et al (2009) Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye. Am J Ophthalmol 148(5):704-710.e2. https:\/\/doi.org\/10.1016\/j.ajo.2009.05.033","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"7476_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1136\/bjo-2024-325267","volume":"109","author":"TJ Patterson","year":"2025","unstructured":"Patterson TJ, Gu W, Eliason D et al (2025) Sympathetic ophthalmia: epidemiology and cohort-based assessment of clinical outcomes. Br J Ophthalmol 109(2):223\u2013227. https:\/\/doi.org\/10.1136\/bjo-2024-325267","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"7476_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3109\/09273948.2015.1092557","volume":"25","author":"AR Payal","year":"2017","unstructured":"Payal AR, Foster CS (2017) Long-term drug-free remission and visual outcomes in sympathetic ophthalmia. Ocul Immunol Inflamm 25(2):190\u2013195. https:\/\/doi.org\/10.3109\/09273948.2015.1092557","journal-title":"Ocul Immunol Inflamm"},{"key":"7476_CR6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ajo.2021.03.048","volume":"228","author":"Standardization of Uveitis Nomenclature (SUN) Working Group","year":"2021","unstructured":"Standardization of Uveitis Nomenclature (SUN) Working Group (2021) Classification criteria for sympathetic ophthalmia. Am J Ophthalmol 228:212\u2013219. https:\/\/doi.org\/10.1016\/j.ajo.2021.03.048","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"7476_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00417-008-0926-0","volume":"247","author":"C Lange","year":"2009","unstructured":"Lange C, Feltgen N, Junker B et al (2009) Resolving the clinical acuity categories \u201chand motion\u201d and \u201ccounting fingers\u201d using the Freiburg Visual Acuity Test (FrACT). Graefes Arch Clin Exp Ophthalmol 247(1):137\u201342. https:\/\/doi.org\/10.1007\/s00417-008-0926-0","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7476_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.55563\/clinexprheumatol\/imrgo2","volume":"40","author":"N Vegas-Revenga","year":"2022","unstructured":"Vegas-Revenga N, Mart\u00edn-Varillas JL, Calvo-R\u00edo V et al (2022) Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients. Clin Exp Rheumatol 40:142\u2013149","journal-title":"Clin Exp Rheumatol"},{"key":"7476_CR9","doi-asserted-by":"publisher","unstructured":"Chan CC, BenEzra D, Hsu SM, Palestine AG, Nussenblatt RB (1985) Granulomas in sympathetic ophthalmia and sarcoidosis. Immunohistochemical study. Arch Ophthalmol. ;103(2):198\u2013202. https:\/\/doi.org\/10.1001\/archopht.1985.01050020050017. PMID: 2579628","DOI":"10.1001\/archopht.1985.01050020050017"},{"issue":"5","key":"7476_CR10","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ajo.2009.07.024","volume":"148","author":"HN Sen","year":"2009","unstructured":"Sen HN, Nussenblatt RB (2009) Sympathetic ophthalmia: what have we learned? Am J Ophthalmol 148(5):632\u20133. https:\/\/doi.org\/10.1016\/j.ajo.2009.07.024","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"7476_CR11","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ophtha.2021.11.013","volume":"129","author":"M Leclercq","year":"2022","unstructured":"Leclercq M, Andrillon A, Maalouf G, S\u00e8ve P, Bielefeld P, Gueudry J, Sen\u00e9 T, Moulinet T, Rouvi\u00e8re B, S\u00e8ne D, Desbois AC, Domont F, Touhami S, El Chamieh C, Cacoub P, Bodaghi B, Biard L, Saadoun D (2022) Anti-Tumor Necrosis Factor \u03b1 versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis Network. Ophthalmology 129(5):520\u2013529 Epub 2021 Nov 16. PMID: 34793830","journal-title":"Ophthalmology"},{"key":"7476_CR12","doi-asserted-by":"crossref","unstructured":"Flores-S\u00e1nchez BC (2025) Sears KS presumed sympathetic ophthalmia after diode laser cyclophotocoagulation for neovascular glaucoma: a case series. Ocul Immunol Inflamm. 13:1\u201310. doi: 10.1080\/09273948.2024.2447838. Epub ahead of print. PMID: 39804100","DOI":"10.1080\/09273948.2024.2447838"},{"issue":"4","key":"7476_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3109\/09273948.2012.689072","volume":"20","author":"J Brour","year":"2012","unstructured":"Brour J, Desjardins L, Lehoang P, Bodaghi B, Lumbroso-Lerouic L, Dendale R, Cassoux N (2012) Sympathetic ophthalmia after proton beam irradiation for choro\u00efdal melanoma. Ocul Immunol Inflamm 20(4):273\u20136. https:\/\/doi.org\/10.3109\/09273948.2012.689072","journal-title":"Ocul Immunol Inflamm"},{"issue":"17","key":"7476_CR14","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1038\/s41433-023-02562-4","volume":"37","author":"K Ullrich","year":"2023","unstructured":"Ullrich K, Patel BCK, Malhotra R (2023) Material risk: vitreoretinal surgery, evisceration, enucleation and sympathetic ophthalmia-where are we currently? Eye (Lond) 37(17):3542\u20133550. https:\/\/doi.org\/10.1038\/s41433-023-02562-4","journal-title":"Eye (Lond)"},{"key":"7476_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ajo.2025.11.021","volume":"282","author":"N Bineshfar","year":"2025","unstructured":"Bineshfar N, Davila N, Shields C, McLaughlin SA, Panneerselvam S, Pradeep T, Wong B, Lee WW (2025) Incidence and risk factors for sympathetic ophthalmia following open globe injuries: a population-based analysis. Am J Ophthalmol 282:338\u2013344. https:\/\/doi.org\/10.1016\/j.ajo.2025.11.021","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"7476_CR16","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1128\/iai.61.7.2872-2878.1993","volume":"61","author":"M Asano","year":"1993","unstructured":"Asano M, Nakane A, Minagawa T (1993) Endogenous gamma interferon is essential in granuloma formation induced by glycolipid-containing mycolic acid in mice. Infect Immun 61(7):2872\u20138. https:\/\/doi.org\/10.1128\/iai.61.7.2872-2878.1993","journal-title":"Infect Immun"},{"issue":"5","key":"7476_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/01.mcp.0000134400.88832.9c","volume":"10","author":"K Marzouk","year":"2004","unstructured":"Marzouk K, Saleh S, Kannass M, Sharma OP (2004) Interferon-induced granulomatous lung disease. Curr Opin Pulm Med 10(5):435\u201340. https:\/\/doi.org\/10.1097\/01.mcp.0000134400.88832.9c","journal-title":"Curr Opin Pulm Med"},{"issue":"5","key":"7476_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00417-008-1002-5","volume":"247","author":"D Doycheva","year":"2009","unstructured":"Doycheva D, Deuter C, Stuebiger N, Zierhut M (2009) Interferon-alpha-associated presumed ocular sarcoidosis. Graefes Arch Clin Exp Ophthalmol 247(5):675\u201380. https:\/\/doi.org\/10.1007\/s00417-008-1002-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07476-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07476-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07476-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:36:30Z","timestamp":1790069790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07476-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":18,"alternative-id":["7476"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07476-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B Bodaghi has received consulting or research fees from Abb Vie, Alimera, Horus Pharma, Novartis, Roche, Thea Pharma\u00a0D Saadoun has received consulting or reserach fees from Abbvie, Roche Chugai, Biocon, Viatris and Celltrion","order":1,"name":"Ethics","label":"Financial disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None were used in this study.","order":2,"name":"Ethics","label":"Generative AI tools or large language models","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"aAl participants provided informed consent. This study has been approved by the Ethics Committee of the French Society of Ophthalmology (IRB 00008855 Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Ophtalmologie IRB#1).","order":3,"name":"Ethics","label":"Human ethics and consent to participate declarations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}